A statutory limit on total federal debt has been in place since 1917. In the past decade, Congress has voted to raise the debt limit ten times and it will now have to do so once again.
The history of the debt limit and its current implications were discussed in a recently updated report from the Congressional Research Service. See “The Debt Limit: History and Recent Increases” (pdf), March 7, 2011. And see, relatedly, “Reaching the Debt Limit: Background and Potential Effects on Government Operations,” February 11, 2011.
Reports from the Congressional Research Service have become such an integral part of the national policymaking process that two CRS reports were cited this month in an opinion (pdf) issued by the Justice Department Office of Legal Counsel concerning the President’s constitutional authority to use military force in Libya.
One of the reports addressed “Instances of Use of United States Armed Forces Abroad, 1798-2010” and the other was on “Haiti: Developments and U.S. Policy Since 1991 and Current Congressional Concerns.”
Remarkably, however, neither of the CRS reports that was cited in the OLC opinion is available on any congressional website, since Congress stubbornly opposes direct public access to CRS products. To find them online, one must turn to non-congressional websites.
Confirmation that the construction of the security perimeter and associated security infrastructure at RAF Lakenheath are still ongoing once again raises questions about whether U.S. nuclear weapons have already been deployed to the base.
Alaskans are sensibly pulling back from the vogue for bans and returning to a western tradition that has worked for more than half a century – one that welcomes innovation but also oversees it closely.
The strength of our nation’s data policy isn’t just in the rules we write, but in how effectively we translate those rules into a system that prioritizes the public good. Join us in this movement to design and build more resilient national data policies.
The human cost is measured in deaths. The financial cost is measured in the $52 billion taxpayers pay annually end stage renal disease – double NASA’s budget.